Core Labs Swings to Q2 Profit with 11c Adj EPS, Beating Q1 Loss
CLB is trading near its 52-week low of $9.72 (7.2% below the low) on elevated volume (1.9× avg).
Summary
Core Laboratories posted Q2 adjusted EPS of 11 cents, a sharp reversal from the Q1 GAAP loss of 2 cents per share on $121.8M revenue. The company provided Q3 guidance with revenue expected between $128.5M and $135.5M and EPS between 12 cents and 20 cents. Q2 revenue fell due to geopolitical disruptions, though the exact figure was not disclosed. The stock is trading near its 52-week low of $9.72, and the earnings beat changes the near-term narrative.
At the time of this announcement, CLB was trading at $9.02 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $455M. The 52-week trading range was $9.72 to $20.36. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.